All Sauce from Weekly Sauce:

An experimental targeted drug could provide a fresh chance for people with recurring head and neck cancer that has grown resistant to other treatments, a new clinical trial says. Ficlatuzumab used in combination with the already approved targeted drug cetuximab (Erbitux) significantly improved progression-free survival in relapsed head and neck cancer patients, according to results…  read on >  read on >

MONDAY, April 3, 2023 (American Heart Association News) — Brain cells have a complex relationship with the blood vessels around them that can greatly affect the vessels’ ability to function, according to a new science report from the American Heart Association. The scientific statement, published Monday in the AHA journal Stroke, highlights new and emerging…  read on >  read on >

U.S. health officials are investigating a Salmonella Infantis outbreak that is likely linked to raw flour. It’s not clear what brand of flour is the culprit. Investigators from the U.S. Centers for Disease Control and Prevention and Food and Drug Administration have identified 12 illnesses and three hospitalizations occurring across 11 states. Reported illnesses started…  read on >  read on >

A cancer diagnosis can be tough to take, and not just for the patient. Caregivers are a vital part of a cancer patient’s care team, but the role can be exhausting. Plenty of caregivers struggle with the challenges of helping their loved one navigate treatment and, hopefully, survival. Research published in the journal Medicine measured…  read on >  read on >